XML 26 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Restricted Stock
Common Stock [Member]
Common Stock [Member]
Restricted Stock
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Beginning balance (in shares) at Dec. 31, 2021     33,534,000        
Beginning balance at Dec. 31, 2021 $ 690,700   $ 9   $ 1,212,823 $ 486 $ (522,618)
Beginning balance (Accounting Standards Update1) at Dec. 31, 2021 (40,105)       (51,417)   11,312
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of common stock options (in shares)     23,000        
Stock Issued During Period, Value, Stock Options Exercised 418       418    
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 46,810       46,810    
Issuance of common stock (in shares)     986,000        
Stock Issued During Period, Shares, Acquisitions     173,000        
Stock Issued During Period, Value, Acquisitions 11,937       11,937    
APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 1,997       1,997    
Stock Issued During Period, Value, Employee Stock Purchase Plan     $ 167        
Stock Repurchased and Retired During Period, Shares     (1,406,000)        
Stock Repurchased and Retired During Period, Value (40,000)       (40,000)    
Other comprehensive income (loss) 5,112         5,112  
Net Income (Loss) (465,264)           (465,264)
Ending balance (in shares) at Dec. 31, 2022     33,477,000        
Ending balance at Dec. 31, 2022 211,605   $ 9   1,182,568 5,598 (976,570)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of common stock options (in shares)     10,000        
Stock Issued During Period, Value, Stock Options Exercised 54       54    
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition $ 43,466       43,466    
Issuance of common stock (in shares) 2,755,000     2,930,000      
Adjustments to Additional Paid in Capital, Warrant Issued $ 15,171       15,171    
APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 2,335       2,335    
Other comprehensive income (loss) (3,131)         (3,131)  
Net Income (Loss) (134,702)           (134,702)
Ending balance (in shares) at Dec. 31, 2023     39,728,000        
Ending balance at Dec. 31, 2023 134,798   $ 9   1,243,594 2,467 (1,111,272)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of common stock options (in shares)     6,000        
Stock Issued During Period, Value, Stock Options Exercised 15       15    
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 45,370       45,370    
Issuance of common stock (in shares)     3,592,000 3,503,000      
Stock Issued During Period, Value, New Issues 27,451 $ 1   $ 1 27,451    
Stock Issued During Period, Shares, Acquisitions     3,908,000        
Stock Issued During Period, Value, Acquisitions $ 48,151       48,151    
Stock Issued During Period, Shares, Restricted Stock Award, Gross     556,000        
Issuance of common stock pursuant to the 2018 ESPP (in shares) 534,912   520,000        
Stock Issued During Period, Value, Employee Stock Purchase Plan $ 2,262       2,262    
Termination of capped calls related to 2020 Convertible Senior Notes 115       115    
Other comprehensive income (loss) 1,134         1,134  
Net Income (Loss) (189,304)           (189,304)
Ending balance (in shares) at Dec. 31, 2024     51,257,000        
Ending balance at Dec. 31, 2024 $ 69,993   $ 10   $ 1,366,958 $ 3,601 $ (1,300,576)